Positives

• Dr. Beate Jaeger’s clinic at Lipid Center North Rhine reports successfully treating thousands of Long COVID patients with HELP (Heparin-induced Extracorporeal LDL Precipitation) apheresis, claiming reduced blood viscosity and improved organ perfusion Health Rising.
  
  

Negatives

• Cardiology reporting raised concerns that patients are not being fully informed these therapies are experimental in Long COVID and that follow-up after expensive courses is often inadequate TCTMD.
  
  

Hurdles & Side Effects

• A typical apheresis course at European clinics costs $10,000-$20,000 for 3-5 weeks of therapy including transportation, accommodation, and lab fees, putting it out of reach for most patients TCTMD.
  
  
• Apheresis requires central venous access and carries risks of any extracorporeal blood-filtration procedure TCTMD (citrate reactions, hypotension, line-site infection), and patients in the US must travel to Germany, Switzerland, or Cyprus to receive HELP apheresis for Long COVID.